Insulin Therapy Guidelines
Initial Insulin Dosing
- The American Diabetes Association recommends starting with basal insulin at 10 units per day or 0.1-0.2 units/kg/day for insulin-naïve patients with type 2 diabetes 3, 4
- The American Diabetes Association suggests setting fasting plasma glucose target and choosing an evidence-based titration algorithm for insulin-naïve patients with type 2 diabetes 4
- For patients with type 2 diabetes, the dose should be increased by 2 units every 3 days to reach fasting glucose target without hypoglycemia 4
- For hypoglycemia, the American Diabetes Association recommends determining the cause and lowering the dose by 10-20% if no clear reason is found 4
Basal-Bolus Regimen
- The American College of Endocrinology recommends a total daily insulin dose between 0.3-0.5 units/kg for insulin-naive patients or those on low doses 1, 2
- Half of the total daily insulin dose should be allocated to basal insulin (1-2 times daily) 1, 2
- The other half should be allocated to rapid-acting insulin (divided three times daily before meals) 1, 2
- Lower doses are recommended for patients with higher hypoglycemia risk, such as older patients (>65 years), those with renal failure, or poor oral intake 1, 2
Basal-Plus Approach
- The American College of Endocrinology recommends a basal-plus approach for patients with mild hyperglycemia, decreased oral intake, or undergoing surgery 1, 2, 5
- This approach consists of a single dose of basal insulin (0.1-0.25 units/kg/day) 1, 2
- Corrective doses of insulin should be added for increased glucose before meals or every 6 hours if nil by mouth 1, 2
Prandial (Bolus) Insulin
- The American Diabetes Association recommends a starting dose of 4 units, 0.1 units/kg, or 10% of the basal dose for prandial insulin 6, 4
- If A1C is <8% when starting mealtime bolus insulin, consider decreasing the basal insulin dose 6, 7
- Rapid-acting analogs are preferred due to their prompt onset of action 6, 7
- The dose should be increased by 1-2 units or 10-15% twice weekly based on blood glucose response 4
Important Considerations
- When switching from intravenous to subcutaneous insulin, estimate requirements based on the average amount infused during the previous 12 hours 2, 5
- The basal-bolus approach is associated with a 4-6 times higher risk of hypoglycemia compared to sliding scale insulin therapy 1, 5
- In controlled settings, the incidence of mild iatrogenic hypoglycemia with basal-bolus is about 12-30% 1, 2
- For patients at high risk of hypoglycemia, consider the basal-plus approach instead of full basal-bolus 1, 5
Special Situations
- For patients receiving enteral nutrition, use basal insulin along with short-acting insulin every 4-6 hours 8
- If tube feeding is interrupted, start intravenous 10% dextrose infusion at 50 mL/h 8
- For patients on glucocorticoids, addition of isophane insulin (0.1-0.3 units/kg/day) to usual insulin regimen can significantly improve glycemic control 8
- Equip patients with an algorithm for self-titration of insulin doses based on self-monitoring of blood glucose 6, 7
- Provide comprehensive education regarding self-monitoring, diet, and hypoglycemia management 6, 7